Cargando…
Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis
Deposition of extracellular matrix (ECM) in the liver is an important feature of liver cirrhosis. Recovery from liver cirrhosis is physiologically challenging, partially due to the ECM in scar tissue showing resistance to cell‐mediated degradation by secreted matrix metalloproteinases (MMPs). Here,...
Autores principales: | Zhao, Peng, Sun, Tian, Lyu, Cheng, Liang, Kaini, Niu, Yudi, Zhang, Yuying, Cao, Chenhui, Xiang, Canhong, Du, Yanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896053/ https://www.ncbi.nlm.nih.gov/pubmed/36494102 http://dx.doi.org/10.1002/advs.202203315 |
Ejemplares similares
-
Response to a Comment on “Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis”
por: Zhao, Peng, et al.
Publicado: (2023) -
Comment on “Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis”
por: Dolivo, David M., et al.
Publicado: (2023) -
Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
por: Zhao, Peng, et al.
Publicado: (2023) -
Synthetic liver fibrotic niche extracts achieve in vitro hepatoblasts phenotype enhancement and expansion
por: Zhang, Yuying, et al.
Publicado: (2021) -
Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis
por: Dobie, Ross, et al.
Publicado: (2016)